Xyclopent 0.05% Eye Drop

Introduction

Xyclopent is a prescription medication that contains the active ingredient Ciclosporin. It is available under the brand name Xyclopent. This medication is primarily used to treat chronic dry eye disease, a condition characterized by insufficient tear production or poor tear quality.

Uses

Xyclopent is prescribed for the treatment of chronic dry eye disease, also known as keratoconjunctivitis sicca. This condition occurs when the eyes do not produce enough tears to keep them lubricated and comfortable. Chronic dry eye can lead to symptoms such as eye redness, irritation, a sandy or gritty feeling in the eyes, and blurred vision. Xyclopent helps to alleviate these symptoms and promote tear production.

Dosage and Administration

The usual recommended dosage of Xyclopent is one drop in each affected eye twice daily, approximately 12 hours apart. Follow your healthcare provider’s instructions regarding the dosage and frequency of use. To administer the eye drops, tilt your head back slightly, pull down the lower eyelid to create a small pocket, and gently squeeze the dropper to release one drop into the pocket. Avoid touching the tip of the dropper to any surface, including your eye, to prevent contamination.

Mechanism of Action

Ciclosporin, the active ingredient in Xyclopent, works by suppressing the immune response in the eyes. In chronic dry eye disease, inflammation of the ocular surface is believed to play a role in the reduced tear production. By reducing inflammation, Ciclosporin helps to improve tear production and relieve the symptoms of dry eye.

Side Effects

Common side effects may include a temporary burning or stinging sensation in the eyes upon application, blurred vision, eye redness, and eye discomfort. These side effects are usually mild and transient. However, if you experience any severe or persistent side effects, such as eye pain, eye discharge, or changes in vision, seek medical attention.

Drug Interactions

inform your healthcare provider about all medications you are currently taking, including over-the-counter drugs, herbal supplements, and vitamins. Certain medications may interact with Xyclopent, potentially affecting its effectiveness or increasing the risk of side effects. It is particularly important to mention if you are taking immunosuppressant medications or have a history of eye infections.

Precautions

Before using Xyclopent, inform your healthcare provider if you have any known allergies or sensitivities to medications, especially Ciclosporin. Disclose any medical conditions you have, particularly if you have an active eye infection or any other eye conditions. Xyclopent may not be suitable for everyone, and your healthcare provider can help determine if it is the right choice for you.

Storage

Patient Tips

• Wash your hands thoroughly before and after using Xyclopent to prevent the spread of infection.
• If you wear contact lenses, remove them before using the eye drops and wait at least 15 minutes before reinserting them.
• Avoid touching the tip of the dropper to any surface to prevent contamination.
• If you experience any eye discomfort or irritation that persists or worsens, contact your healthcare provider.
• Follow your healthcare provider’s instructions regarding the duration of treatment with Xyclopent.
• Attend regular follow-up appointments with your healthcare provider to monitor your condition and treatment progress.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Capimune 100 mg, soft capsules (Health Professionals SmPC) Available at:
• Litfulo: Uses, Dosage, Side Effects, Warnings Consumer Information (Drugs.com) [Accessed 14 Jun. 2024] (online) Available at:
• Cyclosporine (MedlinePlus) [Accessed 30 Jun. 2024] (online) Available at:
• Doutre MS. [Ciclosporin]. Ann Dermatol Venereol. 2002 Apr;129(4 Pt 1):392-404. [Accessed 11 Jun. 2024] Available at: